Literature DB >> 22261448

The expanded histologic spectrum of myxoid liposarcoma with an emphasis on newly described patterns: implications for diagnosis on small biopsy specimens.

Karen J Fritchie1, John R Goldblum, Raymond R Tubbs, Yang Sun, Paula Carver, Steven D Billings, Brian P Rubin.   

Abstract

The variety of histologic patterns in myxoid liposarcoma is underappreciated. The diversity of these patterns can lead to diagnostic difficulty. We examined the morphologic spectrum of myxoid liposarcoma by cataloguing and describing different patterns identified in biopsy and resection specimens of 46 primary, recurrent, and metastatic myxoid liposarcomas. The patterns identified in the 46 cases included traditional myxoid (43 [93%]), traditional round cell (17 [37%]), pseudoacinar (24 [52%]), lipoblast-rich (13 [28%]), island (11 [24%]), lipomatous (10 [22%]), stromal hyalinization (7 [15%]), cord-like (5 [11%]), nested (3 [7%]), chondroid metaplasia (2 [4%]), and hemangiopericytoma (HPC)-like (1 [2%]). Island and nested patterns had not previously been described. The diagnosis of myxoid liposarcoma was confirmed by fluorescence in situ hybridization studies for DDIT3 (also known as CHOP) rearrangement. The morphologic spectrum of myxoid liposarcoma spans well beyond its typical appearance of spindle cells in a myxoid stroma with a prominent vascular pattern. Awareness of the variety of histologic patterns is critical to avoid misdiagnosis, especially in small biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22261448     DOI: 10.1309/AJCP90YNOKBAGCDM

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  Quantification of fat content in lipid-rich myxoid liposarcomas with MRI: a single-center experience with survival analysis.

Authors:  Gokhan Kuyumcu; Brian P Rubin; Jennifer Bullen; Hakan Ilaslan
Journal:  Skeletal Radiol       Date:  2018-06-08       Impact factor: 2.199

2.  Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.

Authors:  Liam A McDonnell; Judith V M G Bovée; Bram Heijs; Stephanie Holst-Bernal; Marieke A de Graaff; Inge H Briaire-de Bruijn; Mar Rodriguez-Girondo; Michiel A J van de Sande; Manfred Wuhrer
Journal:  Lab Invest       Date:  2020-04-27       Impact factor: 5.662

3.  Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy.

Authors:  Wei-Lien Wang; Daniela Katz; Dejka M Araujo; Vinod Ravi; Joseph A Ludwig; Jonathan C Trent; Shreyaskumar R Patel; Patrick P Lin; Ashleigh Guadagnolo; Dolores Lòpez-Terrada; Angelo Paola Dei Tos; Valerie O Lewis; Dina Lev; Raphael E Pollock; Gunar K Zagars; Robert S Benjamin; John E Madewell; Alexander J Lazar
Journal:  Clin Sarcoma Res       Date:  2012-12-29

4.  Myxoid liposarcoma in a 91-year-old patient.

Authors:  Brandon S Sheffield; Torsten O Nielsen
Journal:  Mol Cytogenet       Date:  2013-11-19       Impact factor: 2.009

5.  miR-135b, a key regulator of malignancy, is linked to poor prognosis in human myxoid liposarcoma.

Authors:  Y Nezu; K Hagiwara; Y Yamamoto; T Fujiwara; K Matsuo; A Yoshida; A Kawai; T Saito; T Ochiya
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

6.  Hypercellular round cell liposarcoma: A comprehensive cytomorphologic study and review of 8 cases.

Authors:  Sanjay S Chufal; Kundan S Chufal; Prabhat Pant; Ghazala Rizvi; Hari S Pandey; Kedar S Shahi
Journal:  J Cytol       Date:  2017 Apr-Jun       Impact factor: 1.000

7.  Myxoid Liposarcoma: Prognostic Factors and Metastatic Pattern in a Series of 148 Patients Treated at a Single Institution.

Authors:  Francesco Muratori; Leonardo Bettini; Filippo Frenos; Nicola Mondanelli; Daniela Greto; Lorenzo Livi; Alessandro Franchi; Giuliana Roselli; Maurizio Scorianz; Rodolfo Capanna; Domenico Campanacci
Journal:  Int J Surg Oncol       Date:  2018-05-16

8.  An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity.

Authors:  U Krause; D M Ryan; B H Clough; C A Gregory
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

Review 9.  Histopathological landscape of rare oesophageal neoplasms.

Authors:  Gianluca Businello; Carlo Alberto Dal Pozzo; Marta Sbaraglia; Luca Mastracci; Massimo Milione; Luca Saragoni; Federica Grillo; Paola Parente; Andrea Remo; Elena Bellan; Rocco Cappellesso; Gianmaria Pennelli; Mauro Michelotto; Matteo Fassan
Journal:  World J Gastroenterol       Date:  2020-07-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.